Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold? Posted on July 15th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Syncope Due to Iatrogenic Cava Vein Obstruction: Rare Complication of Cardiac Implantable Electronic Device Leads.Next: First-in-man clinical implantation and acute pacing performance of a novel subxiphoidal pacemaker system.
Syncope Due to Iatrogenic Cava Vein Obstruction: Rare Complication of Cardiac Implantable Electronic Device Leads. Posted on July 15th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Severe Tricuspid Regurgitation in a Patient with a Transvenous Dual-chamber Pacemaker: Considerations for Diagnosis and Management.Next: Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?
Severe Tricuspid Regurgitation in a Patient with a Transvenous Dual-chamber Pacemaker: Considerations for Diagnosis and Management. Posted on July 15th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Concurrent lead impedance reduction in both leads of a dual-chamber pacemaker secondary to generator defect.Next: Syncope Due to Iatrogenic Cava Vein Obstruction: Rare Complication of Cardiac Implantable Electronic Device Leads.